News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Virpax Pharmaceuticals Engages Destum Partners to Direct Strategic Global Partnering Efforts
Wednesday, January 11, 2023Virpax Pharmaceuticals Inc a company specializing in developing nonaddictive products for pain management posttraumatic stress disorder central nervous system CNS disorders and viral barrier indications today announced that the Company has engaged De...
AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline
Tuesday, January 10, 2023AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma Inc CinCor a USbased clinicalstage biopharmaceutical company focused on developing novel treatments
Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases
Tuesday, January 10, 2023Ipsen and Albireo announced that they have entered into a definitive merger agreement under which Ipsen will acquire Albireo a leading innovator in bileacid modulators to treat pediatric and adult cholestatic liver diseases The anticipated acquisitio...
Atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression
Saturday, January 07, 2023Atai Life Sciences a clinicalstage biopharmaceutical company focused on mental health announced that while PCN Rketamine demonstrated signals of efficacy across all timepoints out to two weeks
Helix and QIAGEN Form Exclusive Global Partnership to Develop and Commercialize Companion Diagnostics for Hereditary Diseases
Friday, January 06, 2023Helix the leading population genomics and viral surveillance company in the nation announced today a global strategic partnership with QIAGEN NV the leading global
SciSparc Ltd. Announces Efficacy of Psychedelic-Based Obesity Treatment of Clearmind Medicine Inc. in Pre-Clinical Trial
Friday, January 06, 2023The results are in connection with the provisional patent application for treating metabolic syndromes including obesity with Clearmind based on SciSparcs CannAmides active ingredient Palmitoylethanolamide and Clearminds MEAI submitted in September
Kane Biotech Announces First Distribution Agreement for its coactiv+™ Antimicrobial Hydrogel
Thursday, January 05, 2023Kane Biotech Inc has announced a recent distribution agreement with Salud Pharma SA for the distribution of its coactiv Antimicrobial Hydrogel wound care and DermaKB scalp care products
Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of AT-007 (Govorestat) in Europe
Thursday, January 05, 2023Applied Therapeutics Inc a clinicalstage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need today
Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
Wednesday, January 04, 2023Biocytogen Pharmaceuticals Beijing Co Ltd a clinicalstage biotechnology company with a focus on the antibody discovery and development based on its proprietary
Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar
Wednesday, January 04, 2023Procaps Group SA a leading integrated LatAm healthcare and pharmaceutical conglomerate today announced the termination of its previouslyreported definitive agreement the SPA to acquire Grupo Somar from the sellers under the SPA As previously reported...
